Cognitive Deficit Clinical Trial
Official title:
Recovery After Medical or Surgical Treatment - A Prospective Cohort Study
NCT number | NCT03286439 |
Other study ID # | NA-1-2017 |
Secondary ID | |
Status | Completed |
Phase | |
First received | |
Last updated | |
Start date | November 13, 2017 |
Est. completion date | July 6, 2018 |
Verified date | September 2018 |
Source | Zealand University Hospital |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
This study aims to investigate the in-hospital care as well as the cognitive status, quality of life, physical function and risk of anxiety and depression, sleep disorders and drug use in a Danish cohort of both medical and surgical patients with acute critical illness without admittance to ICU (Intensive Care Unit) treatment, at three and twelve months after hospital discharge.
Status | Completed |
Enrollment | 101 |
Est. completion date | July 6, 2018 |
Est. primary completion date | July 6, 2018 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - Patients > 18 years of age - Admitted to surgical or medical department > 3 days - Admitted with one of the following diagnoses: - Pneumonia - Heart failure - Pulmonary embolism - Acute myocardial infarction - Pyelonephritis - Patients undergoing non-elective open or laparoscopic abdominal surgery (not including elective procedures, diseases of the appendix, diseases of the gallbladder, liver, spleen, kidney, pancreas and emergency hernia surgery without bowel resection) Exclusion Criteria: - Permanently incompetent patients not able to consent - Not able to speak and understand Danish - Discharged from the hospital for terminal care - Patients transferred to another hospital during the stay - Patients living outside the Region of Zealand - Patients admitted under duress or actively psychotic - Patients that are blind or severely visually impaired. |
Country | Name | City | State |
---|---|---|---|
Denmark | Zealand University Hospital | Køge |
Lead Sponsor | Collaborator |
---|---|
Zealand University Hospital |
Denmark,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Cognitive function | Cognitive Function measured by The Repeatable Battery for The Assesment of Neuropsychological Status (RBANS) | 3 months after discharge | |
Secondary | Cognitive function after one year | Cognitive function measured with The Repeatable Battery for the Assessments of Neuropsychological Status (RBANS) evaluation at 12 months after discharge from hospital | 12 months after discharge | |
Secondary | Rehabilitation after 3 months | This will be investigated by filling out a checklist of community support and contact to health care system at 3 month follow up | 3 months after discharge | |
Secondary | Self-reported health related quality of life | This will be investigated by filling out a questionnaire named SF 36, Short Form Health Survey. | 3 months after discharge | |
Secondary | Self-reported health related quality of life | This will be investigated by filling out a questionnaire named SF 36, Short Form Health Survey. | 12 months after discharge | |
Secondary | Objective assessment of physical function | This will be investigated by filling out a checklist called CPAx, The Chelsea Critical Care Physical Assessment Tool. | 3 months after discharge | |
Secondary | Objective assessment of physical function | This will be investigated by filling out a checklist called CPAx, The Chelsea Critical Care Physical Assessment Tool | 12 months after discharge | |
Secondary | Mortality | The mortality of the patients within 90 days after hospital discharge. | 90 days after discharge | |
Secondary | Consumption of opioids | Percentage of patients with a daily consumption of opioids at hospital admission and 90 days after discharge | 90 days after discharge | |
Secondary | Consumption of statins days after discharge | Percentage of patients with a daily consumption of statins at hospital admission and at 90 days after discharge | 90 days after discharge | |
Secondary | Consumption of anti-depressants | Percentage of patients with a daily consumption of anti-depressants at hospital admission and at 90 days after discharge | 90 days after discharge | |
Secondary | Sleepiness | This will be investigated by filling out Epworth Sleepiness Scale | At inclusion | |
Secondary | Sleepiness | This will be investigated by filling out Epworth Sleepiness Scale | 3 months after discharge | |
Secondary | Sleepiness | This will be investigated by filling out Epworth Sleepiness Scale | 12 months after discharge | |
Secondary | Insomnia | This will be investigated by filling out Insomnia Severity Index | At inclusion | |
Secondary | Insomnia | This will be investigated by filling out Insomnia Severity Index | 3 months after discharge | |
Secondary | Insomnia | This will be investigated by filling out Insomnia Severity Index | 12 months after discharge | |
Secondary | Sleep Quality | This will be investigated by filling out Pittsburgh Sleep Quality Index | At inclusion | |
Secondary | Sleep Quality | This will be investigated by filling out Pittsburgh Sleep Quality Index | 3 months after discharge | |
Secondary | Sleep Quality | This will be investigated by filling out Pittsburgh Sleep Quality Index | 12 months after discharge | |
Secondary | Information processing speed | This will be investigated by filling out the Trail Making Test Part A | 3 months after discharge | |
Secondary | Information processing speed | This will be investigated by filling out the Trail Making Test Part A | 12 months after discharge | |
Secondary | Executive function | This will be investigated by filling out the Trail Making Test Part B | 3 months after discharge | |
Secondary | Executive function | This will be investigated by filling out the Trail Making Test Part B | 12 months after discharge | |
Secondary | Rehabilitation after 12 months | This will be investigated by filling out a checklist of Community support and contact to health care system at 3 month follow up | 12 months | |
Secondary | Consumption of sleep medication | Percentage of patients with a daily consumption of sleep medication at hospital admission and 90 days after discharge | At inclusion | |
Secondary | Consumption of sleep medication | Percentage of patients with a daily consumption of sleep medication at hospital admission and 90 days after discharge | 90 days after discharge | |
Secondary | Consumption of sleep medication | Percentage of patients with a daily consumption of sleep medication at hospital admission and 90 days after discharge | 12 months after discharge |
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT04961112 -
Evaluating the Efficacy of Cranial Electrotherapy Stimulation in Mitigating Anxiety-induced Cognitive Deficits
|
N/A | |
Completed |
NCT03695614 -
Cognitive Remediation Therapy for Participants With Late-Life Schizophrenia
|
N/A | |
Active, not recruiting |
NCT05879562 -
Validation of a Digital Self-Administered Cognitive Screening Tool: MoCA-XpressO
|
N/A | |
Recruiting |
NCT04251624 -
Investigating the Use of Goal Management Therapy in Improving Cognitive Functioning in Public Safety Personnel With PTSD
|
N/A | |
Not yet recruiting |
NCT02763397 -
Deep Brain Stimulation (DBS) of the Nucleus Basalis of Meynert (NbM) in Patients With Parkinson's Disease
|
N/A | |
Recruiting |
NCT04051528 -
Do Combinatorial Training Lead to Better Cognition and Daily Participation in TBI Persons With Cognitive Impairments
|
N/A | |
Recruiting |
NCT03036319 -
Patient-Centered NeuroRehabilitation (PCN)
|
N/A | |
Recruiting |
NCT05251454 -
Studying the Effects of Brain Stimulation on Cognitive Control and Associated EEG in Human Subjects.
|
N/A | |
Completed |
NCT05063669 -
Cognitive Intervention in Attention Deficit and Hyperactivity Disorder
|
N/A | |
Completed |
NCT02964221 -
Cognitive Changes After Major Joint Replacement
|
N/A | |
Not yet recruiting |
NCT05605366 -
Minocycline In Neurocognitive Outcomes - Sickle Cell Disease
|
Phase 1 | |
Completed |
NCT02214342 -
Virtual Reality Based Balance Training in People With Mild Cognitive Impairment
|
N/A | |
Terminated |
NCT03032471 -
Swiss SOS MoCA - DCI Study
|
||
Recruiting |
NCT04456777 -
Effect of Vortioxetine on Cognitive Symptoms in Patients With Schizophrenia
|
Early Phase 1 | |
Recruiting |
NCT04204239 -
Validation Study SCOBES-AR
|
||
Withdrawn |
NCT04457271 -
Goal Management Training in Individuals With PTSD
|
N/A | |
Terminated |
NCT03034109 -
Transcranial Direct Current Stimulation (tDCS) in Post-Stroke Working Memory Deficits
|
N/A | |
Recruiting |
NCT05802680 -
Neurocognitive Effects of Non-Invasive Near-Infrared Light Stimulation
|
N/A | |
Active, not recruiting |
NCT02847403 -
Long-acting Exenatide and Cognitive Decline in Dysglycemic Patients
|
Phase 3 | |
Withdrawn |
NCT04654130 -
Neurofeedback Effectiveness Trial in PTSD
|
N/A |